FDA Finds Another Carcinogen in Certain Valsartan Heart Meds
Tablets tainted with N-nitrosodiethylamine, a suspected human carcinogen
Gains in Insurance Coverage Seen for Lesbian, Gay, Bisexual Adults
However, in post-ACA era, lesbian, gay, bisexual adults still report trouble affording care
Pharmacovigilance Needed for Rheumatology Patients
American College of Rheumatologists urges health care providers to monitor for adverse events
AHA: Resistant Hypertension Diagnosis, Tx Guidelines Updated
Ruling out Rx non-compliance, white coat syndrome, and interfering medications necessary
No Apparent Short-Term Cancer Risk From Recalled Valsartan
For single cancer outcomes, risk for colorectal, uterine cancer increased, but not significantly so
Single, Fixed-Dose Combo Pills Improve Hypertension Outcomes
Findings show improved outcomes may be due to better medication adherence
Highest Opioid-Related Mortality Seen in Construction Jobs
Proportional mortality ratios for heroin-, prescription opioid-related deaths elevated in construction field
Fingolimod Cuts Multiple Sclerosis Relapses in Pediatric Patients
Compared with interferon beta-1a, less lesion accumulation seen on MRI but more adverse events
Medicaid Benefits for Addiction Treatment Expanded After ACA
Decreases in states imposing annual service limits, requiring preauthorization for services
Data Age in Clinical Trials Is About Three Years at Publication
Trials funded by government were associated with significantly longer time to publication
